The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.'s (OTCPK:BWVI) Novel Topical Ketamine Delivery

Author's Avatar
Apr 18, 2023

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects